SCHEMBL13989014

SCHEMBL13989014

CCCCOC(=O)c1ccc(NC(=O)[C@@H]2C[C@H](C)CC[C@H]2C(C)C)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.65
RAB9A P51151 7/20 0.55
HSD17B10 Q99714 2/20 0.55
HPGD P15428 2/20 0.53
RECQL P46063 1/20 0.53
ALDH1A1 P00352 5/20 0.49
NPC1 O15118 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
CASP1 P29466 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 3/20 0.46
KMT2A Q03164 4/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 3/20 0.45
GAA P10253 1/20 0.45
POLB P06746 1/20 0.44
GLA P06280 1/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5439860 0.89 TRPM8 (0.67) TRPM8RAB9AHPGDALDH1A1NPC1
SCHEMBL13989015 0.89 TRPM8 (0.67) TRPM8RAB9AHPGDALDH1A1NPC1
SCHEMBL12173068 0.86 RAB9A (0.58) RAB9AHSD17B10HPGDRECQLALDH1A1
SCHEMBL13989013 0.85 TRPM8 (0.76) TRPM8RAB9AHPGDALDH1A1NPC1
SCHEMBL2628763 0.81 TRPM8 (0.70) TRPM8RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL13989012 0.81 TRPM8 (0.67) TRPM8RAB9AHPGDALDH1A1NPC1
SCHEMBL2297046 0.81 TRPM8 (0.77) TRPM8RAB9AALDH1A1L3MBTL1KMT2A
SCHEMBL2628649 0.81 TRPM8 (0.77) TRPM8RAB9AALDH1A1L3MBTL1KMT2A
SCHEMBL369792 0.80 TRPM8 (0.72) TRPM8RAB9AALDH1A1NPC1L3MBTL1
SCHEMBL4886771 0.80 TRPM8 (0.72) TRPM8RAB9AHPGDALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080300314-A1 Cooling Compounds GIVAUDAN SA (CH) 2008-12-04 US disclosed
US-20080300314-A1 Cooling Compounds GIVAUDAN SA (CH) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300314-A1 Cooling Compounds TAS2R42, TAS2R4, TAS2R41 TRPM8 73/4885RAB9A 3882/4885HSD17B10 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.